Pasithea Therapeutics Corp (KTTA)

Pasithea Therapeutics Corp Stock Analysis & Ratings

KTTA Stock Chart & Stats

Day’s Range$0.93 - $0.9772
52-Week Range$0.85 - $8.50
Previous Close$0.96
Average Volume (3M)504.21K
Market Cap$21.33M
P/E Ratio-5.2
Next EarningsMar 30, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
EPS (TTM)-0.18



P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Pasithea Therapeutics Corp’s price range in the past 12 months?
Pasithea Therapeutics Corp lowest stock price was $0.85 and its highest was $8.50 in the past 12 months.
    What is Pasithea Therapeutics Corp’s market cap?
    Pasithea Therapeutics Corp’s market cap is $21.33M.
      What is Pasithea Therapeutics Corp’s price target?
      Currently, no data Available
      What do analysts say about Pasithea Therapeutics Corp?
      Not enough analysts have published a price target to provide an average price target.
      When is Pasithea Therapeutics Corp’s upcoming earnings report date?
      Pasithea Therapeutics Corp’s upcoming earnings report date is Mar 30, 2022 which is 50 days ago.
        How were Pasithea Therapeutics Corp’s earnings last quarter?
        Currently, no data Available
        Is Pasithea Therapeutics Corp overvalued?
        According to Wall Street analysts Pasithea Therapeutics Corp’s price is currently Overvalued.
          Does Pasithea Therapeutics Corp pay dividends?
          Pasithea Therapeutics Corp does not currently pay dividends.
          What is Pasithea Therapeutics Corp’s EPS estimate?
          Pasithea Therapeutics Corp’s EPS estimate is $0.03.
            How many shares outstanding does Pasithea Therapeutics Corp have?
            Pasithea Therapeutics Corp has 22,860,000 shares outstanding.
              What happened to Pasithea Therapeutics Corp’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Pasithea Therapeutics Corp?
              Currently, no hedge funds are holding shares in KTTA


              Pasithea Therapeutics Corp Stock Analysis

              Smart Score
              Not Ranked
              Price Target
              No data currently available
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Pasithea Therapeutics Corp

              Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis